ROCKVILLE, Md. – May 18, 2023 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, has published a report that was designed to establish ...
Universal genetic testing at an institution identified pathogenic germline variants in 14% of patients with genitourinary cancer. More than 1 in 8 patients with genitourinary malignancies in a recent ...
In this study, 3,319 unselected, pan-cancer Jordanian patients diagnosed between April 2021 and September 2022 received GGT. Pathogenic germline variant (PGV) frequency among patients who were ...
Figure A: Spectrum of germline variants in our cohort and statistics on variant classification and pathogenicity categories. BRCA1, BRCA2, and RAD51D are among the top three genes. The genetic testing ...
In their article, Subbiah and Kurzrock 1 contend that the most powerful argument for universal testing is that every patient afflicted with cancer deserves a full diagnosis, which is only possible ...
Patients with TP53 germline variants have an increased risk of secondary sarcoma post-radiation therapy. The 15-year risk of sarcoma for TP53 pathogenic variant carriers is 8.8%, higher than the ...
The genetic testing showed that 31% (116/373) of the patients had at least one deleterious germline variant, and co-variants were found in four patients. Patients with deleterious homologous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback